Betaine And Homocysteine — The Methyl Donor Nobody Mentions
Quick Read Your body has two separate systems for recycling homocysteine, an amino acid that builds up after you eat
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
CoQ10 is a molecule your body produces naturally that helps cells convert food into energy, particularly in your brain, which is very energy-hungry. Your body makes less CoQ10 as you age, and low levels have been linked to worse cognitive performance in older adults. CoQ10 also protects brain cells from damage caused by oxidative stress, a type of cellular decay.
Research shows CoQ10 can meaningfully reduce depression symptoms across five randomized controlled trials. However, the evidence for reducing fatigue specifically is weak, with only two trials showing conflicting results. Studies in animal models show promise for protecting against brain aging, but a major unsolved question remains: whether CoQ10 supplements can actually cross the blood-brain barrier in humans to reach the brain in useful amounts.
CoQ10 is safe and well-tolerated even at high doses. A typical dose is 100-400mg daily taken with food containing fat, which improves absorption. The mechanistic case for why it should help brain energy is sound, but we lack large-scale human trials proving it improves cognitive fatigue in healthy people.
Verdict: CoQ10 is a reasonable, low-risk choice for midlife and older adults concerned about brain energy, though the direct evidence for improving cognitive fatigue is still emerging.
What if the reason your brain feels foggy, slow and utterly spent by mid-afternoon has less to do with stress, poor sleep or “just getting older”, and more to do with a molecule your body is quietly producing less of every year? Not a hormone. Not a neurotransmitter. A compound most people have never heard of, sitting deep inside the engine rooms of every single cell in your body, keeping the lights on.
That molecule is CoQ10, Coenzyme Q10, and while it has become something of a staple in the heart health and anti-ageing supplement world, its relationship with brain energy and cognitive fatigue is only beginning to be properly understood. The picture is genuinely interesting. It is also more complicated, and more honest, than most supplement brands will tell you.
Vitacuity has analysed over 1.77 million research papers and selected the most relevant findings on this topic. Here is what the science actually shows, including where it’s strong, where it’s promising, and where we simply don’t know yet.
To understand why CoQ10 matters for your brain, you first need to understand what it actually does.
Inside almost every cell in your body are mitochondria, tiny structures often called the cell’s power stations. Their job is to convert the food you eat into a usable form of energy called ATP (adenosine triphosphate). ATP is the currency your body runs on. Your heart, your muscles, your immune system, and crucially, your brain, all depend on it.
CoQ10 sits at the very heart of this energy production process. It works as an electron carrier within what’s called the mitochondrial electron transport chain, essentially a relay system that generates ATP. Without CoQ10 doing its job as a relay runner, the chain slows down, ATP output drops, and your cells, including your 86 billion brain cells, have less fuel to work with [7, 11].
But CoQ10 has a second, equally important role: it is the body’s only fat-soluble antioxidant produced endogenously, meaning your body makes it itself, inside every cell [11]. In the brain, where oxygen consumption is disproportionately high compared to other organs, oxidative stress (the cellular equivalent of rust) is a constant threat. CoQ10 helps neutralise the free radicals that cause this damage, protecting neurons from degradation and keeping brain cell membranes intact [6, 7].
Here’s the catch: your body’s natural production of CoQ10 declines significantly with age. You also find it in three forms, ubiquinol (reduced), ubiquinone (oxidised), and a semiquinone radical form, and its ability to shift between these states is central to both its energy-production and antioxidant roles [6]. When CoQ10 levels fall, both functions suffer. And your brain, as one of the most energy-hungry organs in the body, feels that decline acutely.
So when people describe cognitive fatigue, that sense of mental heaviness, the inability to sustain focus, the brain that just won’t fire properly, mitochondrial underperformance is a genuinely plausible explanation. The question is whether CoQ10 supplementation can do anything meaningful about it.
The most direct human evidence connecting CoQ10 to brain function comes from a 2023 observational study published in a peer-reviewed journal, which examined 64 older adults aged 65–99 (average age 76.67 years, 75% women) [8].
Researchers measured plasma CoQ10 levels alongside cognitive functioning and executive function, the higher-order brain skills involved in planning, decision-making and mental flexibility. They controlled for other factors known to affect cognitive ageing, including physical activity levels and nutritional status.
The headline finding: plasma CoQ10 was significantly associated with cognitive functioning and executive function, even after controlling for those other variables. Participants with lower CoQ10 levels performed worse on cognitive assessments [8].
The researchers concluded that declining cognitive capacity in older adults may be partly related to reduced antioxidant defences, as reflected by lower CoQ10 levels, suggesting CoQ10 isn’t just a bystander in brain ageing, but a meaningful participant.
Evidence grade: Promising, but important caveats apply. This was an observational study of 64 people, which means we can see an association but cannot prove causation. Low CoQ10 might cause cognitive decline, or both might be downstream effects of a third factor, poorer mitochondrial health in general. We need randomised controlled trials in cognitively healthy older adults to take this further.
This is where the science gets genuinely nuanced, and where intellectual honesty matters most.
A 2026 systematic review and meta-analysis, the gold standard design in clinical research, pooled data from five randomised controlled trials (RCTs) with a total of 474 participants [1]. The trials included people with depression associated with conditions like multiple sclerosis, breast cancer and polycystic ovary syndrome, as well as people with primary depressive disorders including major depression and bipolar disorder.
The results for depressive symptoms were meaningful. CoQ10 supplementation produced a statistically significant reduction in depression scores compared to placebo or standard treatment, with a standardised mean difference (SMD) of -0.68 (95% CI: -1.02 to -0.33, P <0.01) [1]. In practical terms, an SMD of around 0.68 is considered a moderate effect, noticeable, not trivial.
But here is where we need to be straight with you: the fatigue outcome told a different story. Only two of the five trials measured fatigue specifically, and the pooled result was not statistically significant (SMD: -0.33; 95% CI: -1.38 to 0.72; P =0.54) [1]. The heterogeneity between those two trials was also very high (I² = 89%), meaning the results differed substantially from each other, which makes drawing firm conclusions impossible.
Evidence grade: Promising for mood; Conflicted and inconclusive for fatigue specifically. The mood finding across five RCTs is genuinely encouraging. The fatigue data, based on only two trials with conflicting results, is simply not strong enough yet to say CoQ10 reliably reduces fatigue as a standalone outcome. This doesn’t mean it doesn’t, it means we don’t have enough good trials to know.
One of the most interesting recent research angles concerns a group of chronic conditions that share overlapping symptoms: Gulf War Illness, fibromyalgia, ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and Long COVID [3, 15].
A 2025 review published in a peer-reviewed journal found that despite their different origins, all four conditions share remarkably similar underlying biological features: mitochondrial dysfunction, oxidative stress, neuroinflammation, immune dysregulation and neuroendocrine disruption [3, 15]. The researchers used the term “low-energy associated disorders” to describe them collectively.
Because CoQ10 plays a direct role in correcting each of these biological mechanisms, supporting mitochondrial function, acting as an antioxidant and anti-inflammatory agent, and protecting against cell death, the review identified a clear rationale for CoQ10 supplementation in managing these conditions [3, 15]. Reported benefits of supplementary CoQ10 in all four conditions were reviewed, and the researchers also flagged a potentially interesting finding: CoQ10 may help reduce telomere shortening, a biological marker of accelerated cellular ageing seen in these disorders.
Evidence grade: Promising to Early Stage. The mechanistic case is coherent and well-constructed. But it is important to note this is a review article, not a new clinical trial. The evidence for CoQ10’s benefit in these specific conditions varies, some supporting data exists, but large, well-controlled trials are still needed.
Two related clinical reviews published in 2014 examined the broader relationship between mitochondrial dysfunction and chronic fatigue, and assessed natural supplement interventions including CoQ10 [10, 12].
Both reviews concluded that loss of mitochondrial function is a central driver of the excess fatigue seen across many chronic diseases. At the molecular level, this involves breakdown of the inner mitochondrial membrane’s electrical potential, disruption of the electron transport chain, and failure to transport critical metabolites, all of which reduce ATP production [10, 12].
Critically, both reviews highlighted clinical trial evidence suggesting that oral supplementation with CoQ10, alongside other mitochondrial support agents such as L-carnitine, alpha-lipoic acid and NADH, could significantly reduce fatigue and help restore mitochondrial function, even in patients with long-term intractable fatigue [10, 12].
Evidence grade: Promising, with important context. These reviews covered clinical trials, not just animal or lab studies. But CoQ10 was assessed as part of combination supplement protocols, not in isolation, so the specific contribution of CoQ10 to fatigue reduction within these studies is difficult to disentangle from the effects of other supplements given alongside it.
Animal research provides some of the clearest mechanistic evidence for what CoQ10 depletion does to the ageing brain.
A 2016 study examining normal ageing mice (15 months versus 6 months old) found that mitochondrial oxygen consumption and CoQ10 content were both significantly reduced in older animals [14]. Alongside these biochemical changes, the aged mice showed measurable declines in motor function, movement rate and voluntary activity, early markers that mirror the kind of Parkinson’s-like changes seen in the brain over time.
When exogenous (externally supplemented) water-soluble CoQ10 was administered to the aged mice, it restored mitochondrial oxygen consumption, improved motor function, and reduced the accumulation of a problematic protein called phosphorylated alpha-synuclein in the motor cortex, a hallmark of neurodegeneration [14].
Separate reviews from 2025 and 2023 further explored CoQ10’s neuroprotective potential across Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, migraine and multiple sclerosis, noting its dual role in energy production and antioxidant defence as the mechanism by which it may protect neurons from degeneration [2, 6, 13].
Evidence grade: Early Stage for direct brain ageing applications. The mouse research is mechanistically compelling. But we cannot directly translate these findings to humans without clinical trial data, and as we’ll discuss below, getting CoQ10 into the human brain is not straightforward.
Let’s be direct about the gaps, because they matter.
The blood-brain barrier problem. This is the most significant open question in the entire CoQ10-and-brain field. The blood-brain barrier (BBB) is a highly selective filter that controls what passes from the bloodstream into the brain. CoQ10 is a large, fat-soluble molecule, and a 2025 review specifically examined whether supplemental CoQ10 can actually cross this barrier in humans [4].
The honest conclusion? We don’t know for certain. There is evidence from animal models, and some indirect human evidence, but the question of whether supplemented CoQ10 reliably crosses the human BBB in meaningful quantities remains unresolved [4]. This may well explain why animal studies of CoQ10 in neurodegenerative diseases have consistently produced more positive results than human clinical trials, the supplement may not be reaching the brain in sufficient concentrations to replicate the animal findings [4, 11].
Researchers are actively working on new formulations, including idebenone and MitoQ, that may cross the BBB more effectively, but these are not yet established [11].
We lack dedicated RCTs in cognitively healthy older adults. Almost all the human trial data on CoQ10 and cognitive outcomes comes from people who already have a diagnosable condition, depression, MS, cancer, Parkinson’s. We have very limited RCT evidence on whether CoQ10 supplementation meaningfully improves cognitive energy, focus or mental clarity in healthy people who are simply experiencing the normal cognitive effects of ageing.
The fatigue evidence is genuinely thin. Despite the mechanistic logic being sound, the 2026 meta-analysis [1] found only two RCTs measuring fatigue as an outcome, with conflicting results and high heterogeneity. The case for CoQ10 reducing cognitive fatigue specifically is built more on mechanism than on direct clinical trial proof.
Optimal dose and formulation are unknown. Studies have used a wide range of doses and CoQ10 forms (ubiquinone vs. ubiquinol, standard vs. enhanced-absorption formulations). Whether ubiquinol is meaningfully superior to ubiquinone for brain outcomes in humans hasn’t been definitively established.
Here is what a sensible, informed person should do with this information.
The mechanistic case for CoQ10’s role in brain energy is genuinely strong, it is not speculative that your brain needs CoQ10 to produce energy efficiently, and it is not speculative that CoQ10 levels decline with age [6, 7, 11]. The association between low CoQ10 and worse cognitive performance in older adults is real, even if observational [8]. The mood data from five RCTs is encouraging [1]. The fatigue-mechanism story across chronic fatigue conditions is coherent and accumulating [3, 10, 12, 15].
What we don’t yet have is a clean, large-scale RCT showing that CoQ10 supplementation significantly improves cognitive fatigue or mental clarity in healthy older adults. That trial is needed and hasn’t been done.
So where does that leave you?
CoQ10 is one of the better-evidenced and safest supplements available. It is fat-soluble, but toxicity at normal supplementation doses has not been demonstrated, it is well-tolerated even at high doses [11]. If you are over 40, your natural CoQ10 production is almost certainly lower than it was at 25. If you are taking statins (cholesterol-lowering drugs), it is worth knowing that statins can further reduce the body’s CoQ10 synthesis, this is a well-established mechanism, though the clinical implications remain debated.
Given the safety profile, the biologically plausible mechanism, the emerging human evidence on mood and cognition, and the real-world cost of deficiency as you age, supplementing with CoQ10 is a reasonable, evidence-informed choice for people in midlife and beyond who are concerned about brain energy. The BBB question means we can’t yet guarantee how much reaches your brain, but your heart, muscles and other organs will benefit from it too, and the systemic reduction in oxidative stress is likely to help rather than hurt.
A typical supplementation dose used in clinical trials ranges from 100mg to 400mg daily. Taking it with a meal containing healthy fats improves absorption, given its fat-soluble nature.
Think of CoQ10 not as a proven cure for cognitive fatigue, it isn’t that yet, but as a well-reasoned, low-risk investment in keeping your mitochondria running as well as possible, at a point in your life when they need the most support.
[1] Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2026). *Journal of Clinical Psychopharmacology*. DOI: 10.1097/JCP.0000000000002112 | https://pubmed.ncbi.nlm.nih.gov/41294251/
[2] Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling (2025). DOI: 10.1080/13813455.2025.2541698 | https://pubmed.ncbi.nlm.nih.gov/40762836/
[3] Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies (2025). *International Journal of Molecular Sciences*. DOI: 10.3390/ijms26189044 | https://pubmed.ncbi.nlm.nih.gov/41009608/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12469932/
[4] Coenzyme Q10 and the Blood-Brain Barrier: An Overview (2025). https://pubmed.ncbi.nlm.nih.gov/40283578/
[5] Coenzyme Q, neuroprotective potential in aging rats (2025). DOI: 10.1007/s11011-025-01721-8 | https://pubmed.ncbi.nlm.nih.gov/41182484/
[6] Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases (2023). https://pubmed.ncbi.nlm.nih.gov/37946741/
[7] Preclinical and Clinical Role of Coenzyme Q10 Supplementation in Various Pathological States (2022). DOI: 10.1055/a-1835-1738 | https://pubmed.ncbi.nlm.nih.gov/35724675/
[8] Coenzyme Q10 Levels Associated With Cognitive Functioning and Executive Function in Older Adults (2023). https://pubmed.ncbi.nlm.nih.gov/35908233/
[9] Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2026). *Journal of Clinical Psychopharmacology*. DOI: 10.1097/JCP.0000000000002112 | https://pubmed.ncbi.nlm.nih.gov/41294251/
[10] Mitochondrial dysfunction and chronic disease: treatment with natural supplements (2014). https://pubmed.ncbi.nlm.nih.gov/24473982/
[11] Coenzyme Q10 effects in neurological diseases (2021). *Physiological Research*. DOI: 10.33549/physiolres.934712 | https://pubmed.ncbi.nlm.nih.gov/35199552/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054193/
[12] Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements (2014). https://pubmed.ncbi.nlm.nih.gov/26770107/
[13] Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling (2025). DOI: 10.1080/13813455.2025.2541698 | https://pubmed.ncbi.nlm.nih.gov/40762836/
[14] Early-onset motor impairment and increased accumulation of phosphorylated α-synuclein in the motor cortex of normal aging mice are ameliorated by coenzyme Q (2016). https://pubmed.ncbi.nlm.nih.gov/27143639/
[15] Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies (2025). *International Journal of Molecular Sciences*. DOI: 10.3390/ijms26189044 | https://pubmed.ncbi.nlm.nih.gov/41009608/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12469932/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Your body has two separate systems for recycling homocysteine, an amino acid that builds up after you eat
Quick Read B vitamins become increasingly important for brain health after 40 because your body absorbs them less efficiently with
The nutrients that matter, the forms that work, and the claims to ignore.
